Osteonecrosis of the jaw in an AIDS patient: a case report by unknown
Zushi et al. AIDS Research and Therapy  (2015) 12:13 
DOI 10.1186/s12981-015-0049-8CASE REPORT Open AccessOsteonecrosis of the jaw in an AIDS patient:
a case report
Yusuke Zushi, Kazuma Noguchi*, Kuniyasu Moridera, Kazuki Takaoka and Hiromitsu KishimotoAbstract
We report a rare case of osteonecrosis of the jaw following necrotizing gingivitis in a Japanese AIDS patient.
Intraoral examination showed exposed necrotic bone in the left mandible and spontaneous loss of teeth. This
patient was successfully treated with highly active anti-retroviral therapy combined with minimally invasive surgical
procedures to remove the osteonecrosis of the jaw.
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Oral complications of human immunodeficiency virus
(HIV) infection, such as oral candidiasis, hairy leukopla-
kia, Kaposi’s sarcoma, and herpes simplex labialis, are
sometimes the first sign of the infection and often indi-
cate progression to AIDS [1,2]. Cases with definitive
diagnosis of AIDS with osteonecrosis of the jaw are ex-
tremely rare in Japan and other developed countries. We
present herein a rare case of osteonecrosis of the jaw in
a 37-year-old Japanese AIDS patient treated with minim-
ally invasive surgery.Case report
A 37-year-old Japanese man complaining of discomfort
in the left mandibular molar area was referred to our
department. Six months earlier, he had noticed pain on
swallowing and loosening of the teeth in the left man-
dibular molar area. Medical and family histories were
non-contributory. The patient had a history of smoking
and alcohol consumption, but no drug allergies. Gen-
eral examination showed the patient was underweight
(body mass index (BMI), 14.2 kg/m2), and he com-
plained of a 5-kg reduction in weight over the pre-
ceding 2 months.
Extraoral examination showed facial asymmetry caused
by swelling of the left cheek. No paresthesia was noted
over the lower lip. Lymph node swelling was palpable* Correspondence: knoguchi@hyo-med-ac.jp
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unless otherwise stated.bilaterally in the submandibular regions, but lymph nodes
felt normal to the touch. Intraoral examination showed
necrosis of the left mandible with exposed bone, a missing
right mandibular canine tooth, necrotizing gingivitis and
stomatitis that had destroyed the buccal mucosa and floor
of the mouth (Figure 1A). Orthopantomography showed
ill-defined, irregular bony destruction on the lower alveo-
lar ridge extending from the left canine tooth to the left
second molar, with floating teeth at the right canine and
first premolar in the right mandible (Figure 1B). Gallium-
67 citrate scintigraphy showed abnormal uptake in the left
mandible (Figure 1C). Computed tomography (CT)
showed a bone-destroying lesion occupying the left alveo-
lar ridge, extending from the mucosal tissue of the
left cheek to the floor of the mouth. Multiple enlarged
lymph nodes were observed in the cervical area. Three-
dimensional (3D)-CT showed destruction of cortical bone
in the left mandible (Figure 2A). Results of chest radiog-
raphy and electrocardiography were within normal limits.
On first impression, malignant tumor such as lymph-
oma or multiple myeloma was strongly suspected from
the clinical findings and imaging results. The patient
was hospitalized immediately, and the gingival lesion
was biopsied. Histological examination showed no evi-
dence of malignancy, but did reveal severe inflammatory
granulation with lymphoid aggregates. We considered
the possibility of osteomyelitis of the mandible and ad-
ministered clyndamycin at 2400 mg/day as antimicrobial
therapy. The patient was malnourished on admission,
and nutritional status improved with the administration of
electrolytes and fluids. Daily irrigation of the mandibularhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Findings on admission. A) Left mandible with
denudation of bone, spontaneous loss of the teeth, necrotizing
gingivitis and stomatitis. B) Orthopantomography show ill-defined,
irregular bony destruction in the left mandible. C) Gallium-67 citrate
scintigraphy shows abnormal uptake in the left mandible.
Figure 2 Changes in appearance on 3D-CT from on admission.
(A) to the 2-month follow-up examination (B). A) 3D-CT showed
ill-defined, irregular destruction of cortical bone in the left mandible
on admission. B) Sequestra of the mandible were seen as radiopaque
areas resembling “islands of bone” at the 2-month follow-up.
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sloughed tissue was removed.
Hematological examination showed reductions in
the white blood cell count (3,950/μL; normal, 4,000-
9,000/μL), red blood cell count (3.07 × 106/μL; normal,
3.80-5.30 × 106/μL), hemoglobin (8.9 g/dL; normal, 12.0-
16.5 g/dL), and hematocrit (28.1%; normal, 35.0-45.0%).
Serology yielded negative results for HBV and HCV, and
results of liver and renal function tests were unremarkable.
Rouleaux formation of red blood cells was observed, butblood levels of M protein were within normal limits. Ven-
ereal examination showed positive results, and HIV testing
was performed.
HIV enzyme-linked immunosorbent assay testing
showed positive results. The patient was found to be
anti-HIV-antibody positive. The patient then reported he
was homosexual. His CD4 count was 78/μL, and the
plasma HIV-RNA load was 2.5 × 105 copies/mL.
HAART was started with emtricitabine at 200 mg/day,
tenofovir disoproxil fumarate/abacavir at 300 mg/day,
and raltegravir potassium at 1600 mg/day to treat AIDS,
followed by ethambutol at 1000 mg/day, rifampicin at
300 mg/day, clarythromycin at 800 mg/day, and cipro-
floxacin at 1200 mg/day for the non-tuberculous myco-
bacterial infection.
One month after initiating HAART, the HIV-RNA
load markedly decreased (from 2.5 × 105 copies/mL to
less than 44 copies/mL), but the CD4 count was 78/μL.
For 3 months after initiation of HAART, CD4 counts
showed no dramatic changes.
At the 2-month follow-up, necrotic bone of the man-
dible was seen as radiopaque areas resembling “islands
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(Figure 2B). The sequestrum of the mandible subse-
quently separated from living bone, with a layer of
new bone (termed involucrum) forming around the nec-
rotic bone.
At the 6-month follow-up examination, without per-
formance of any radical surgery, spontaneous exfoliation
of the necrotic bone was observed, partially resorbed by
granulation tissue or spontaneously expelled through the
mucosa; in the latter instances, necrotic bone was re-
movable through less-invasive surgical procedures. Ex-
tensive scarring was seen around the mandibular defect
(Figure 3A). CT showed that living bone was very thin in
the left mandible, with a risk of pathological fracture due
to a significant volume of bone loss (Figure 3B). Ten
months after starting HAART, the CD4+ lymphocyte
count had increased from 78 cells/μL to 280 cells/μL
(Figure 4). The patient regained more than 10 kg of
body weight compared to status on admission and
his general condition was markedly better (BMI in-
creased from 14.2 kg/m2 to 19.1 kg/m2). With continuedFigure 3 Appearance at the 6-month follow-up examination.
In the absence of radical surgery, spontaneous exfoliation of
sequestrum is observed, showing spontaneous expulsion through
the mucosa. A) Extensive scarring is seen around the mandibular
defect. B) On 3D-CT, the living bone is seen to be very thin in the
left mandible.
Figure 4 Treatments and changes in HIV-RNA viral load and
CD4 count. Viral load decreased from 2.5 × 105 copies/mL
to <44 × 105 copies/mL with treatment. During the first 10 months
after treatment, CD4+ lymphocyte count increased from 78 cells/μL
to 280 cells/μL.antiretroviral therapy, the patient has shown good im-
munological recovery, with no signs of relapse as of one
and a half years after starting HAART.
Discussion
Oral disorders occur in approximately 60% of HIV/AIDS
cases and may present as a wide range of lesions, not-
ably fungal, viral, and bacterial infections and malig-
nant neoplasms such as Kaposi’s sarcoma [2]. Cases
involving definitive diagnosis of AIDS from a finding
of osteonecrosis of the jaw are very rare in Japan. We
initially suspected malignant tumor or osteomyelitis
of the mandible, and AIDS was not considered at all.
Due to the strong suspicion of osteomyelitis of the
mandible, antimicrobial therapy was initiated at the
same time.
HAART was started after obtaining results from
HIV testing, and the HIV-RNA load subsequently de-
creased markedly from 2.5 × 105 copies/mL to less
than 44 copies/mL. CD4 counts, however, showed lit-
tle change within 3 months. HIV-positive patients
with CD4+ lymphocyte counts below 200 cells/ml
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and HIV-positive patients with a viral load greater
than 10,000 copies/ml show active viremia [2]. It is
currently impossible to determine the relative contri-
butions of local treatment, improved nutritional sta-
tus and improved immunological status following
HAART to the arrest of the subacute phase of osteo-
necrosis of the mandible seen within 2–6 months of
follow-up. If not adequately treated, the condition of
this patient might well have developed to noma (cancrum
oris). Noma represents a sequence of odontogenic in-
fections characterized by an irregular pattern of rap-
idly spreading necrosis of the gingiva, mucosa, fascia,
muscles, and skin. In developed countries, noma is
extremely rare and affects only patients with severe
immunosuppression or blood dyscrasia [3,4]. By con-
trast, noma persists in the poorest developing coun-
tries, mostly typically in Africa. If not adequately
treated, patients with noma will die, usually from sec-
ondary infection, septicemia, severe dehydration and
malnutrition, and rarely hemorrhage [5-8]. Noma is
suggested to frequently start as necrotizing gingivitis
[3], and the treatment regimen for this precursor dis-
ease has to include antibiotic treatment appropriate to
anaerobic infections, frequent mouth-washing and
gentle tooth cleaning to remove and aerate the nec-
rotic anaerobic pabulum. However, depending on the
extent of intra-oral damage, debridement of necrotic
bone, extraction of mobile teeth and dental rehabilita-
tion may be required.
In the present case, whether the living bone in the left
mandible needed reinforcement with a reconstruction
plate to minimize the risk of fracture is highly controver-
sial. If pathological fracture occurred due to reduced
bone strength in the mandible, consideration would
need to be given to subsequent reconstruction, such as a
reconstruction plate, or autogenous bone grafting. We
think that avoiding reconstruction may be the most
practical option from the perspective of quality of life
(QOL) at present. However, the use of HAART is associ-
ated with loss of bone mineral density independent of
HIV infection [9,10]. This decrease in bone density is
suggested to be a direct effect of protease inhibitors on
bony remodeling or an indirect effect on vitamin D me-
tabolism [11]. Furthermore, initiation of HAART can
trigger “immune reconstitution inflammatory syndrome”
(IRIS), an inflammatory cascade that can decrease BMD
and place patients at even greater risk of osteoporotic
fracture [12]. We assume that HAART use may have
had some bearing on adverse events and fracture risk in
this patient.
The patient currently has a good appetite, and is able
to chew quite well despite extensive scarring around the
defect. His QOL remains moderately good.Consent
Written informed consent was obtained from the patient
for publication of this case report and the accompanying
images.
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